Product NDC: | 62756-757 |
Proprietary Name: | Olanzapine |
Non Proprietary Name: | Olanzapine |
Active Ingredient(s): | 20 mg/1 & nbsp; Olanzapine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62756-757 |
Labeler Name: | Sun Pharmaceutical Industries Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090881 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120228 |
Package NDC: | 62756-757-66 |
Package Description: | 1 BLISTER PACK in 1 CARTON (62756-757-66) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Code | 62756-757-66 |
Proprietary Name | Olanzapine |
Package Description | 1 BLISTER PACK in 1 CARTON (62756-757-66) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Product NDC | 62756-757 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Olanzapine |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20120228 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharmaceutical Industries Limited |
Substance Name | OLANZAPINE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC] |